Live Breaking News & Updates on Lon ekf

Stay informed with the latest breaking news from Lon ekf on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Lon ekf and stay connected to the pulse of your community

Insider Buying: EKF Diagnostics Holdings plc (LON:EKF) Insider Acquires £26,000 in Stock

EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) insider Christopher H. B. Mills purchased 100,000 shares of the stock in a transaction that occurred on Friday, March 22nd. The stock was purchased at an average price of GBX 26 ($0.33) per share, with a total value of £26,000 ($32,857.32). EKF Diagnostics Stock Performance Shares […]

Ekf-diagnostics-holdings , Diagnostics-holdings , Get-free-report , Middle-east , Hemo-control , Ekf-diagnostics , Lon-ekf , Ekf , Medical , Insider-trading , Nsider-trades

EKF Diagnostics Holdings plc (LON:EKF) Insider Buys £26,000 in Stock

EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) insider Christopher H. B. Mills acquired 100,000 shares of EKF Diagnostics stock in a transaction that occurred on Friday, March 22nd. The shares were purchased at an average cost of GBX 26 ($0.33) per share, for a total transaction of £26,000 ($33,099.94). EKF Diagnostics Stock Up […]

Diagnostics-company-profile , Diagnostics-holdings , Ekf-diagnostics-holdings , Get-free-report , Middle-east , Hemo-control , Ekf-diagnostics , Lon-ekf , Ekf , Medical , Insider-trading

EKF Diagnostics (LON:EKF) Shares Cross Above Two Hundred Day Moving Average of $28.07

EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 28.07 ($0.36) and traded as high as GBX 31.90 ($0.41). EKF Diagnostics shares last traded at GBX 30.75 ($0.39), with a volume […]

Diagnostics-holdings , Diagnostics-company-profile , Ekf-diagnostics-holdings , Get-free-report , Stock-down , Middle-east , Hemo-control , Ekf-diagnostics , Lon-ekf , Ekf , Medical

EKF Diagnostics (LON:EKF) Shares Pass Below Two Hundred Day Moving Average of $28.44

EKF Diagnostics Holdings plc (LON:EKF – Get Free Report)’s share price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 28.44 ($0.35) and traded as low as GBX 27 ($0.33). EKF Diagnostics shares last traded at GBX 28 ($0.34), with […]

Ekf-diagnostics-holdings , Diagnostics-holdings , Diagnostics-company-profile , Get-free-report , Middle-east , Hemo-control , Ekf-diagnostics , Lon-ekf , Ekf , Medical , Stocks

EKF Diagnostics (LON:EKF) Stock Price Passes Below 200 Day Moving Average of $37.78

EKF Diagnostics Holdings plc (LON:EKF – Get Rating) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 37.78 ($0.47) and traded as low as GBX 27.10 ($0.34). EKF Diagnostics shares last traded at GBX 27.10 ($0.34), with a volume of 277,685 shares traded. […]

Diagnostics-holdings , Ekf-diagnostics-holdings , Get-rating , Stock-down , Middle-east , Hemo-control , Ekf-diagnostics , Lon-ekf , Ekf , Medical , Stocks

EKF Diagnostics (LON:EKF) Shares Pass Below Two Hundred Day Moving Average of $39.07

Shares of EKF Diagnostics Holdings plc (LON:EKF – Get Rating) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 39.07 ($0.48) and traded as low as GBX 28.80 ($0.36). EKF Diagnostics shares last traded at GBX 28.80 ($0.36), with a volume of 121,640 shares […]

Diagnostics-holdings , Diagnostics-company-profile , Get-rating , Trading-down , Middle-east , Hemo-control , Ekf-diagnostics , Lon-ekf , Ekf , Medical , Stocks

EKF Diagnostics Holdings plc (LON:EKF) to Issue Dividend Increase – GBX 1.20 Per Share

EKF Diagnostics Holdings plc (LON:EKF – Get Rating) announced a dividend on Tuesday, March 29th, Upcoming.Co.Uk reports. Investors of record on Thursday, November 3rd will be given a dividend of GBX 1.20 ($0.02) per share on Thursday, December 1st. This represents a yield of 2.35%. The ex-dividend date is Thursday, November 3rd. This is a […]

Ekf-diagnostics-holdings , Upcoming-co-uk , Diagnostics-holdings , Get-rating , Middle-east , Diaspect-hemoglobint-low , Hemo-control , Ekf-diagnostics , Lon-ekf , Ekf , Medical

EKF Diagnostics executive directors to receive £500,000 performance bonus each | 10 March 2021

10 March 2021 | 13:55pm
StockMarketWire.com - Point-of-care business EKF Diagnostics has announced its executive directors will receive an executive performance bonus of approximately £500,000 each.
The company said its remuneration committee (RemCo) had determined that the performance-related payments were 'appropriate' and reflected the 'continued value creation for shareholders in the current financial year'.
The bonus has been calculated using a 4.4p increase over the baseline share price used in the share based incentive scheme, which was reset in August 2020 to 29p.
Based on the closing mid-market price of 71.75p on 31 December 2020, EKF's share price has improved by 31.1% since 5 August 2020.
EKF Diagnostics said: 'Following payment of the bonus, RemCo considers that the remaining unpaid amounts under the incentive continue to provide strong motivation to the executive directors, who will receive a further potential variable reward in the event of an exit, equal to 5% of the excess value obtained over the revised baseline price of 33.4p per share.'

Diagnostics-holdings , Ekf-diagnostics-holdings-plc , Lon-ekf , Ekf-l , Ekf , பரிசோதனை-ஹோல்டிங்ஸ் ,

EKF Diagnostics sees performance 'comfortably' ahead of expectations amid ongoing momentum | 12 January 2021

12 January 2021 | 08:56am
StockMarketWire.com - Point-of-care business EKF Diagnostics said it expected annual performance for the year ending 31 December 2020 and for the first quarter of the new to top market expectations amid ongoing momentum.
The company confirmed that 'continued strong trading will result in the performance for the year ending 31 December 2020 being comfortably ahead of already upgraded market expectations.'
Trading in the core business in the final quarter had continued to improve 'significantly and ongoing demand for the PrimeStore MTM COVID-19 sample collection device remained strong through to the end of the year and will continue to do so into the first quarter of 2021,' the company said.

Diagnostics-holdings , Ekf-diagnostics-holdings-plc , Lon-ekf , Ekf-l , Ekf , பரிசோதனை-ஹோல்டிங்ஸ் ,